Review



quantikine human vegf a elisa kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    R&D Systems quantikine human vegf a elisa kit
    Quantikine Human Vegf A Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1838 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/us12599680-490-36-42
    Average 96 stars, based on 1838 article reviews
    quantikine human vegf a elisa kit - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    human vegf quantikine elisa kit  (Bio-Techne corporation)
    97
    Bio-Techne corporation human vegf quantikine elisa kit
    Human Vegf Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/custom%40dve00%4042546142
    Average 97 stars, based on 1 article reviews
    human vegf quantikine elisa kit - by Bioz Stars, 2026-08
    97/100 stars
    		  Buy from Supplier
    quantikine human vegf a elisa kit  (R&D Systems)
    96
    R&D Systems quantikine human vegf a elisa kit
    Quantikine Human Vegf A Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/us12599680-490-36-42
    Average 96 stars, based on 1 article reviews
    quantikine human vegf a elisa kit - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    vegfa  (R&D Systems)
    96
    R&D Systems vegfa
    Abundance of proteins significantly associated with incomplete response to anti-VEGF therapy. A total of 10 proteins were found to be significantly regulated in substantial edema versus no edema. A, Upregulated proteins determined by mass spectrometry at time points 1 to 3 (T1-T3) <t>included</t> <t>afamin</t> (AFM), alpha-1B-glycoprotein (A1BG), and angiotensinogen (AGT). B, Downregulated proteins included cystatin-C (CST3), clusterin (CLU), apolipoprotein E (APOE), epidermal growth factor-containing fibulin-like extracellular matrix protein (EFEMP1), Ig lambda chain V-I (IGLV1), latent transforming growth factor beta-binding protein 2 (LTBP2), and reelin (RELN). C, The increased level of afamin was confirmed by ELISA. D, <t>VEGFA</t> concentration assessed by ELISA. There was no significant difference in VEGFA between the substantial edema and no edema groups. Box plots indicate median, min and max and first and third quartiles. ∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001. ELISA = enzyme-linked immunosorbent assay; LFQ = Label-Free Quantification.
    Vegfa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/pmc12972968-106-11-13
    Average 96 stars, based on 1 article reviews
    vegfa - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    human vegf elisa kit  (R&D Systems)
    96
    R&D Systems human vegf elisa kit
    Gal-3BP positively regulates VEGFA production in PDAC. A . Clustered heatmap of the protein expression profile for PDX_PC 110,621 treated with rhGal-3BP, rhEGF, or rhGal-3BP+rhEGF combination. Red indicates upregulated protein levels, whereas green shows downregulated cases. The bottom panel indicates the VEGFA-VEGFR2 pathway enriched in C1 cluster, as shown by WikiPathway 2021 analysis. B and C . mRNA ( B ) and protein expression ( C ) of VEGFA in PDX_PC 110,621 after Gal-3BP knockdown by shRNA. D . VEGFA secretion measured by <t>ELISA</t> in PDX_PC 110,621 after Gal-3BP knockdown. E . The secretion of VEGFA measured in Panc-1 cells after Gal-3BP overexpression. F . Transwell migration of HUVEC co-cultured with control PDX_PC 110,621 or with Gal-3BP knockdown. The graph on right shows relative migration rate. Scale bar: 50 μm. G – H . Expression correlation analysis between Gal-3BP and VEGFA for mRNA ( G ) or protein ( H ), using cBioportal database.* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns (not significant)
    Human Vegf Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/pmc13112773-368-6-11
    Average 96 stars, based on 1 article reviews
    human vegf elisa kit - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    human elisa kit  (R&D Systems)
    96
    R&D Systems human elisa kit
    Gal-3BP positively regulates VEGFA production in PDAC. A . Clustered heatmap of the protein expression profile for PDX_PC 110,621 treated with rhGal-3BP, rhEGF, or rhGal-3BP+rhEGF combination. Red indicates upregulated protein levels, whereas green shows downregulated cases. The bottom panel indicates the VEGFA-VEGFR2 pathway enriched in C1 cluster, as shown by WikiPathway 2021 analysis. B and C . mRNA ( B ) and protein expression ( C ) of VEGFA in PDX_PC 110,621 after Gal-3BP knockdown by shRNA. D . VEGFA secretion measured by <t>ELISA</t> in PDX_PC 110,621 after Gal-3BP knockdown. E . The secretion of VEGFA measured in Panc-1 cells after Gal-3BP overexpression. F . Transwell migration of HUVEC co-cultured with control PDX_PC 110,621 or with Gal-3BP knockdown. The graph on right shows relative migration rate. Scale bar: 50 μm. G – H . Expression correlation analysis between Gal-3BP and VEGFA for mRNA ( G ) or protein ( H ), using cBioportal database.* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns (not significant)
    Human Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dve00/Human+VEGF+Quantikine+ELISA+Kit/pm41778428-59-5-8
    Average 96 stars, based on 1 article reviews
    human elisa kit - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Abundance of proteins significantly associated with incomplete response to anti-VEGF therapy. A total of 10 proteins were found to be significantly regulated in substantial edema versus no edema. A, Upregulated proteins determined by mass spectrometry at time points 1 to 3 (T1-T3) included afamin (AFM), alpha-1B-glycoprotein (A1BG), and angiotensinogen (AGT). B, Downregulated proteins included cystatin-C (CST3), clusterin (CLU), apolipoprotein E (APOE), epidermal growth factor-containing fibulin-like extracellular matrix protein (EFEMP1), Ig lambda chain V-I (IGLV1), latent transforming growth factor beta-binding protein 2 (LTBP2), and reelin (RELN). C, The increased level of afamin was confirmed by ELISA. D, VEGFA concentration assessed by ELISA. There was no significant difference in VEGFA between the substantial edema and no edema groups. Box plots indicate median, min and max and first and third quartiles. ∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001. ELISA = enzyme-linked immunosorbent assay; LFQ = Label-Free Quantification.

    Journal: Ophthalmology Science

    Article Title: Serial Aqueous Humor Proteomics in Diabetic Macular Edema

    doi: 10.1016/j.xops.2025.101056

    Figure Lengend Snippet: Abundance of proteins significantly associated with incomplete response to anti-VEGF therapy. A total of 10 proteins were found to be significantly regulated in substantial edema versus no edema. A, Upregulated proteins determined by mass spectrometry at time points 1 to 3 (T1-T3) included afamin (AFM), alpha-1B-glycoprotein (A1BG), and angiotensinogen (AGT). B, Downregulated proteins included cystatin-C (CST3), clusterin (CLU), apolipoprotein E (APOE), epidermal growth factor-containing fibulin-like extracellular matrix protein (EFEMP1), Ig lambda chain V-I (IGLV1), latent transforming growth factor beta-binding protein 2 (LTBP2), and reelin (RELN). C, The increased level of afamin was confirmed by ELISA. D, VEGFA concentration assessed by ELISA. There was no significant difference in VEGFA between the substantial edema and no edema groups. Box plots indicate median, min and max and first and third quartiles. ∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001. ELISA = enzyme-linked immunosorbent assay; LFQ = Label-Free Quantification.

    Article Snippet: Samples were diluted 500-fold for afamin (ELH-AFM-1, RayBiotech) and 2-fold for VEGFA (DVE00, R&D Systems).

    Techniques: Mass Spectrometry, Binding Assay, Enzyme-linked Immunosorbent Assay, Concentration Assay, Quantitative Proteomics

    Gal-3BP positively regulates VEGFA production in PDAC. A . Clustered heatmap of the protein expression profile for PDX_PC 110,621 treated with rhGal-3BP, rhEGF, or rhGal-3BP+rhEGF combination. Red indicates upregulated protein levels, whereas green shows downregulated cases. The bottom panel indicates the VEGFA-VEGFR2 pathway enriched in C1 cluster, as shown by WikiPathway 2021 analysis. B and C . mRNA ( B ) and protein expression ( C ) of VEGFA in PDX_PC 110,621 after Gal-3BP knockdown by shRNA. D . VEGFA secretion measured by ELISA in PDX_PC 110,621 after Gal-3BP knockdown. E . The secretion of VEGFA measured in Panc-1 cells after Gal-3BP overexpression. F . Transwell migration of HUVEC co-cultured with control PDX_PC 110,621 or with Gal-3BP knockdown. The graph on right shows relative migration rate. Scale bar: 50 μm. G – H . Expression correlation analysis between Gal-3BP and VEGFA for mRNA ( G ) or protein ( H ), using cBioportal database.* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns (not significant)

    Journal: Cell Communication and Signaling : CCS

    Article Title: The Galectin-3-binding protein promotes angiogenesis in pancreatic cancer via simultaneous upregulation of VEGFA and direct HUVEC activation mediated by and VAMP5-STAT3

    doi: 10.1186/s12964-026-02801-7

    Figure Lengend Snippet: Gal-3BP positively regulates VEGFA production in PDAC. A . Clustered heatmap of the protein expression profile for PDX_PC 110,621 treated with rhGal-3BP, rhEGF, or rhGal-3BP+rhEGF combination. Red indicates upregulated protein levels, whereas green shows downregulated cases. The bottom panel indicates the VEGFA-VEGFR2 pathway enriched in C1 cluster, as shown by WikiPathway 2021 analysis. B and C . mRNA ( B ) and protein expression ( C ) of VEGFA in PDX_PC 110,621 after Gal-3BP knockdown by shRNA. D . VEGFA secretion measured by ELISA in PDX_PC 110,621 after Gal-3BP knockdown. E . The secretion of VEGFA measured in Panc-1 cells after Gal-3BP overexpression. F . Transwell migration of HUVEC co-cultured with control PDX_PC 110,621 or with Gal-3BP knockdown. The graph on right shows relative migration rate. Scale bar: 50 μm. G – H . Expression correlation analysis between Gal-3BP and VEGFA for mRNA ( G ) or protein ( H ), using cBioportal database.* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns (not significant)

    Article Snippet: Secreted VEGF was detected using the Human VEGF ELISA Kit (DVE00, R&D Systems).

    Techniques: Expressing, Knockdown, shRNA, Enzyme-linked Immunosorbent Assay, Over Expression, Migration, Cell Culture, Control